NCT06741111View on ClinicalTrials.gov

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

CompletedOBSERVATIONAL

Enrollment

1,233,970

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

May 27, 2025

Study Completion Date

May 27, 2025

Conditions

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)

Interventions

OTHER

No treatment given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY